Performance on a probabilistic inference task in healthy subjects receiving ketamine compared with patients with schizophrenia

J Psychopharmacol. 2012 Sep;26(9):1211-7. doi: 10.1177/0269881111435252. Epub 2012 Mar 2.

Abstract

Evidence suggests that some aspects of schizophrenia can be induced in healthy volunteers through acute administration of the non-competitive NMDA-receptor antagonist, ketamine. In probabilistic inference tasks, patients with schizophrenia have been shown to 'jump to conclusions' (JTC) when asked to make a decision. We aimed to test whether healthy participants receiving ketamine would adopt a JTC response pattern resembling that of patients. The paradigmatic task used to investigate JTC has been the 'urn' task, where participants are shown a sequence of beads drawn from one of two 'urns', each containing coloured beads in different proportions. Participants make a decision when they think they know the urn from which beads are being drawn. We compared performance on the urn task between controls receiving acute ketamine or placebo with that of patients with schizophrenia and another group of controls matched to the patient group. Patients were shown to exhibit a JTC response pattern relative to their matched controls, whereas JTC was not evident in controls receiving ketamine relative to placebo. Ketamine does not appear to promote JTC in healthy controls, suggesting that ketamine does not affect probabilistic inferences.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anesthetics, Dissociative / administration & dosage
  • Anesthetics, Dissociative / adverse effects*
  • Anesthetics, Dissociative / blood
  • Antipsychotic Agents / therapeutic use
  • Decision Making / drug effects*
  • Diagnostic and Statistical Manual of Mental Disorders
  • Dose-Response Relationship, Drug
  • Double-Blind Method
  • Excitatory Amino Acid Antagonists / administration & dosage
  • Excitatory Amino Acid Antagonists / adverse effects*
  • Excitatory Amino Acid Antagonists / blood
  • Female
  • Humans
  • Ketamine / administration & dosage
  • Ketamine / adverse effects*
  • Ketamine / blood
  • Male
  • Middle Aged
  • Neurotoxicity Syndromes / diagnosis
  • Patient Dropouts
  • Receptors, N-Methyl-D-Aspartate / antagonists & inhibitors*
  • Schizophrenia / blood
  • Schizophrenia / chemically induced
  • Schizophrenia / drug therapy
  • Schizophrenia / physiopathology*
  • Schizophrenic Psychology*
  • Severity of Illness Index
  • Task Performance and Analysis
  • Young Adult

Substances

  • Anesthetics, Dissociative
  • Antipsychotic Agents
  • Excitatory Amino Acid Antagonists
  • Receptors, N-Methyl-D-Aspartate
  • Ketamine